Evidence map›Paper›PMID 39935627›Full record

ReviewFrontiers in psychiatry2024

Pharmacist gatekeeper interventions for suicide prevention: how evidence from developed countries support their role in low- and middle-income countries.

Zixiao Zhou, Fahim Mohamed

Abstract readReview
In one paragraph

Review in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zixiao ZhouFaculty of Medical and Health, The University of Sydney, Sydney, NSW, Australia.
Fahim MohamedFaculty of Medical and Health, The University of Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Approximately 70% of self-poisoning suicides occur in low- and middle-income countries (LMICs).The implementation of pesticide bans has significantly reduced the rate of pesticide self-poisoning in these regions; however, this has been accompanied by a shift toward an increased incidence of pharmaceutical poisoning, highlighting the importance of intervention strategies to prevent pharmaceutical self-poisoning in the future. This report summarizes the existing evidence on community pharmacist gatekeeper interventions aimed at reducing pharmaceutical suicide to discuss their complementary role with pesticide bans in LMICs. Methods: The literature review identified studies published between April 2014 and April 2024 using multiple keywords related to "suicide," "intervention," "pharmacist" and "gatekeeper" in various library databases. Data were extracted into a table for analysis. Results: Only eight relevant studies were found during the search period, and none quantified the impact of pharmacy gate keeper interventions. Community pharmacists became more confident and willing to intervene after pharmacist gatekeeper training. They demonstrated positive attitudes and improved knowledge and skills in responding to suicidal intent. However, the evidence supporting community pharmacy gatekeeper interventions primarily comes from developed countries. Furthermore, the role of pharmacists in preventing suicide relies on frequent contact between suicidal individuals and pharmacies in developed countries. Conclusion: Pharmacy gatekeeper interventions can be implemented in LMICs as a complement to pesticide bans, provided they are modified and adapted to suit the specific context of these regions. Further research is essential to tailor and implement successful strategies from developed countries to address the unique challenges faced by LMICs.

Indexed as

community pharmacistgatekeeper trainingLMICsself-poisoningsuicide prevention

Identifiers

PMID39935627
PMCPMC11810978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.